1-Testosterone
Systematic (IUPAC) name | |
---|---|
(5S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | |
Clinical data | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Liver |
Identifiers | |
CAS Number | 65-06-5 |
PubChem | CID 579094 |
DrugBank | DB01481 |
ChemSpider | 206590 |
ChEBI | CHEBI:59714 |
Chemical data | |
Formula | C19H28O2 |
Molar mass | 288.42 g/mol |
| |
| |
(verify) |
Δ1-Testosterone (17β-hydroxy-5α-androst-1-en-3-one, 1-Testo, 1-T) is an androgen and anabolic steroid that differs from testosterone by having a 1,2-double bond instead of a 4,5-double bond in its A ring. It was legally sold as a prohormone in the United States until 2005, when it was reclassified as a Schedule III drug.
A 2006 study determined that Δ1-testosterone has a high androgenic and anabolic potency even without being metabolized, so it can be characterized as a typical anabolic steroid. Δ1-Testosterone binds in a manner that is highly selective to the androgen receptor (AR) and has a high potency to stimulate AR-dependent transactivation. In vivo, an equimolar dose of 1-testosterone has the same potency to stimulate the growth of the prostate, the seminal vesicles and the androgen-sensitive levator ani muscle as the reference anabolic steroid testosterone propionate, but unlike it, Δ1-testosterone also increases liver weight.[1]
Doping with Δ1-testosterone can be detected in urine samples using gas chromatography.[2]
A prodrug of Δ1-testosterone is Δ1-androstenedione, which may be synthesized from stanolone acetate.[3]
References
- ↑ Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O, Diel P (August 2006). "17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties". Toxicol. Lett. 165 (2): 149–55. doi:10.1016/j.toxlet.2006.03.001. PMID 16621347.
- ↑ S. Jain, A. Beotra and T. Kaur (2005). "A Case Study: Detection of 1-Testosterone in Urine by GC-MSD" (PDF). Recent Advances in Doping Analysis 13: 407–410.
- ↑ Zhang H, Qiu Z (December 2006). "An efficient synthesis of 5α-androst-1-ene-3,17-dione". Steroids 71 (13-14): 1088–90. doi:10.1016/j.steroids.2006.09.008. PMID 17123559.
|
|